Michael A Minni, DO | |
701 E Cathedral Rd Ste 11, Phila, PA 19128-2128 | |
(267) 766-6321 | |
Not Available |
Full Name | Michael A Minni |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 701 E Cathedral Rd Ste 11, Phila, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568854594 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS020298 (Pennsylvania) | Primary |
Entity Name | On Demand Urgent Care Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053729814 PECOS PAC ID: 5991029712 Enrollment ID: O20150126001443 |
News Archive
A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.
Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Researchers around the world have tried many ways, and for many years, to generate neurons in the lab so they could study them better. Neurons-on-demand might also provide a therapeutic option for replacing neurons lost in neurodegenerative conditions, such as Parkinson's disease.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
› Verified 8 days ago
Entity Name | Roxborough Medical Of Andorra Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134511157 PECOS PAC ID: 0941520670 Enrollment ID: O20150521000045 |
News Archive
A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.
Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Researchers around the world have tried many ways, and for many years, to generate neurons in the lab so they could study them better. Neurons-on-demand might also provide a therapeutic option for replacing neurons lost in neurodegenerative conditions, such as Parkinson's disease.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael A Minni, DO 701 E Cathedral Rd Ste 11, Phila, PA 19128-2128 Ph: () - | Michael A Minni, DO 701 E Cathedral Rd Ste 11, Phila, PA 19128-2128 Ph: (267) 766-6321 |
News Archive
A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.
Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Researchers around the world have tried many ways, and for many years, to generate neurons in the lab so they could study them better. Neurons-on-demand might also provide a therapeutic option for replacing neurons lost in neurodegenerative conditions, such as Parkinson's disease.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
› Verified 8 days ago
John Francis Lozowski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2923 E Thompson St, Phila, PA 19134 Phone: 215-425-3981 Fax: 215-425-8083 | |
Dr. Wayne Hentschel, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2821 Island Ave, Suite 147, Phila, PA 19153 Phone: 212-863-2320 | |
Felix Vershvovsky, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2100 W Girard Ave, Phila, PA 19130 Phone: 215-685-0800 Fax: 215-685-0846 | |
Dr. Philip J. Bell, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6445 Vine Street, Phila, PA 19139 Phone: 215-748-0505 Fax: 215-748-4090 | |
Kem Yenal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1741 Frankford Ave, Suite 100a, Phila, PA 19125 Phone: 215-425-2424 Fax: 215-425-0342 | |
Kantilal J. Shah, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 N Broad St, Phila, PA 19132 Phone: 215-226-8800 Fax: 215-226-8819 | |
Herman Gottlieb, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6557 Roosevelt Blvd, Phila, PA 19149 Phone: 215-535-1900 Fax: 215-535-7950 |